BR9810595A - Medicamentos, compostos de poliidroxibutilpirazina, processo para preparação dos compostos, e, utilização dos compostos. - Google Patents

Medicamentos, compostos de poliidroxibutilpirazina, processo para preparação dos compostos, e, utilização dos compostos.

Info

Publication number
BR9810595A
BR9810595A BR9810595-7A BR9810595A BR9810595A BR 9810595 A BR9810595 A BR 9810595A BR 9810595 A BR9810595 A BR 9810595A BR 9810595 A BR9810595 A BR 9810595A
Authority
BR
Brazil
Prior art keywords
radical
compounds
represent
methylene
choh
Prior art date
Application number
BR9810595-7A
Other languages
English (en)
Portuguese (pt)
Inventor
Georges Bashiardes
Jean-Christophe Carry
Michel Evers
Bruno Filoche
Serge Mignani
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of BR9810595A publication Critical patent/BR9810595A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BR9810595-7A 1997-07-17 1998-07-15 Medicamentos, compostos de poliidroxibutilpirazina, processo para preparação dos compostos, e, utilização dos compostos. BR9810595A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9709059A FR2766183B1 (fr) 1997-07-17 1997-07-17 Medicaments contenant des polyhydroxybutylpyrazines, les polyhydroxybutylpyrazines nouvelles et leur preparation
PCT/FR1998/001543 WO1999003841A1 (fr) 1997-07-17 1998-07-15 Polyhydroxybutylpyrazines, leur preparation et medicaments les contenant

Publications (1)

Publication Number Publication Date
BR9810595A true BR9810595A (pt) 2000-09-12

Family

ID=9509301

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9810595-7A BR9810595A (pt) 1997-07-17 1998-07-15 Medicamentos, compostos de poliidroxibutilpirazina, processo para preparação dos compostos, e, utilização dos compostos.

Country Status (25)

Country Link
US (1) US6288066B1 (cs)
EP (1) EP1001942B1 (cs)
JP (1) JP4443033B2 (cs)
KR (1) KR20010021871A (cs)
CN (1) CN1264368A (cs)
AT (1) ATE243683T1 (cs)
AU (1) AU745905B2 (cs)
BR (1) BR9810595A (cs)
CA (1) CA2296725C (cs)
CZ (1) CZ290896B6 (cs)
DE (1) DE69815854T2 (cs)
DK (1) DK1001942T3 (cs)
ES (1) ES2196595T3 (cs)
FR (1) FR2766183B1 (cs)
HU (1) HUP0004661A3 (cs)
IL (1) IL134039A0 (cs)
MX (1) MXPA00000437A (cs)
NO (1) NO20000199L (cs)
NZ (1) NZ502279A (cs)
PL (1) PL338147A1 (cs)
PT (1) PT1001942E (cs)
RU (1) RU2186773C2 (cs)
SK (1) SK462000A3 (cs)
WO (1) WO1999003841A1 (cs)
ZA (1) ZA986336B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2802816A1 (fr) * 1999-12-23 2001-06-29 Aventis Pharma Sa Association de deoxyfructosazine et d'un antidiabetique inhibiteur d'alpha-glucosidase
FR2802813A1 (fr) * 1999-12-23 2001-06-29 Aventis Pharma Sa Association de deoxyfructosazine et d'un antidiabetique de la famille des biguandes
FR2802815A1 (fr) * 1999-12-23 2001-06-29 Aventis Pharma Sa Association de deoxyfructosazine et d'un antidiabetique agoniste du recepteur gamma-active par le proliferateur de peroxisome
US6794506B2 (en) * 2000-07-21 2004-09-21 Elan Pharmaceuticals, Inc. 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4
MY141521A (en) * 2002-12-12 2010-05-14 Hoffmann La Roche 5-substituted-six-membered heteroaromatic glucokinase activators
DE102005047647A1 (de) * 2005-10-05 2007-04-12 Merck Patent Gmbh a,a'-Dihydroxyketonderivate und deren Verwendung als UV-Filter
US8278459B2 (en) 2007-03-19 2012-10-02 Dsm Ip Assets B.V. UV-filter compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3600052A1 (de) * 1986-01-03 1987-07-09 Merck Patent Gmbh Heterocyclische verbindungen
FR2744365B1 (fr) * 1996-02-06 1998-02-27 Inst Malgache Rech Appl Melanges isolables a partir de graines d'eugenia jambolana lamarck, leur preparation et l'utilisation de ces melanges et certains de leurs constituants comme medicaments

Also Published As

Publication number Publication date
CA2296725C (fr) 2008-11-18
JP2001510185A (ja) 2001-07-31
DE69815854T2 (de) 2004-05-13
PT1001942E (pt) 2003-11-28
HUP0004661A3 (en) 2001-12-28
EP1001942B1 (fr) 2003-06-25
NZ502279A (en) 2002-04-26
IL134039A0 (en) 2001-04-30
PL338147A1 (en) 2000-09-25
NO20000199D0 (no) 2000-01-14
ZA986336B (en) 1999-01-27
MXPA00000437A (es) 2002-04-17
CN1264368A (zh) 2000-08-23
DK1001942T3 (da) 2003-10-20
DE69815854D1 (de) 2003-07-31
RU2186773C2 (ru) 2002-08-10
SK462000A3 (en) 2000-06-12
JP4443033B2 (ja) 2010-03-31
ATE243683T1 (de) 2003-07-15
FR2766183A1 (fr) 1999-01-22
NO20000199L (no) 2000-01-14
AU8810398A (en) 1999-02-10
CZ2000121A3 (cs) 2000-05-17
HUP0004661A2 (hu) 2001-11-28
KR20010021871A (ko) 2001-03-15
CZ290896B6 (cs) 2002-11-13
EP1001942A1 (fr) 2000-05-24
CA2296725A1 (fr) 1999-01-28
US6288066B1 (en) 2001-09-11
WO1999003841A1 (fr) 1999-01-28
ES2196595T3 (es) 2003-12-16
FR2766183B1 (fr) 1999-08-27
AU745905B2 (en) 2002-04-11

Similar Documents

Publication Publication Date Title
BRPI0016395B8 (pt) derivados de adamantano
ES2151640T3 (es) Derivados de urea y amida que tienen actividad inhibidora frente al acat, su preparacion y su uso terapeutico y profilactico.
BR0010716A (pt) Compostos de fenila substituìdos com atividade imunossupressora e composições farmacêuticas
BRPI0215312B8 (pt) composto, uso de um composto, composição farmacêutica, e processo para a preparação de um composto
PT83647B (pt) Processo para a preparacao de novos derivados de benzimidazole com actividade farmacologica e de composicoes farmaceuticas que os contem
BR0209271A (pt) Composto, uso de um composto composição farmacêutica, formulação em aerossol farmacêutica, método para o tratamento de um paciente humano ou animal com uma condição inflamatória e/ou alérgica, e, processo para a preparação de um composto
BR9810592A (pt) Composto, processos para preparar um composto, para tratar ou prevenir doenças do sistema endócrino e para a fabricação de um medicamento, composição farmacêutica, e, uso de um composto
BR9808281A (pt) Compostos, composições farmacêuticas, processo para tratar doenças proliferativas e/ou distúrbios do sistema imune e para preparar um composto, e, uso de um composto
PT96324A (pt) Processo para a preparacao de compostos peptidicos e de composicoes farmaceuticas que os contem
FI865233A0 (fi) Pyrazolinderivat, deras framstaellning och anvaendning som medel med insekticid och akaricid verkan.
PT94925A (pt) Processo para a preparacao de derivados de tiazol e de composicoes farmaceuticas que os contem
PT84171B (pt) Processo para a preparacao de derivados das n alfa-aril-sulfonilamiminoacil-p- -amidinofenil-alaninamidas, bem como dos seus derivados de sintese e das composicoes farmaceuticas que os contem
ES2061848T3 (es) Compuestos triciclos, procedimientos para su preparacion y composiciones farmaceuticas que los comprenden.
BR9810021A (pt) Derivados 9-oxima-eritromicina
PT84530B (pt) Processo para a preparacao de 2-azolilmetil-2-aril-1,3-dioxolanos, dos seus sais e de composicoes farmaceuticas que os contem
PT81855B (pt) Processo de preparacao de arilciclobutilalquilaminas e de composicoes farmaceuticas que as contem
BR0015586A (pt) Derivado de espiro[ 12h-1-benzopiran-2,4'-piperidina ], e, uso de um derivado de espiro [2h-1-benzopiran-2,4'-piperidina]
AR013163A1 (es) Uso de composiciones que contienen diclorofenil imidazoldioxolano para la preparacion de un medicamento para tratar la dermatitis seborreica, caspa,psoriasis y acne, composiciones propiamente dichas, y un articulo de fabricacion que contiene dicha composicion
AR007052A1 (es) Un derivado de carbohidrato, su uso y una composicion farmaceutica que lo comprende
BR9813217A (pt) Tetraciclos, processo para a produção dos mesmos e preparações farmacêuticas contendo estes compostos
DK624989D0 (da) Hidtil ukendte forbindelser
ES2086528T3 (es) Nuevos compuestos biciclicos sustituidos con amino.
ES2037758T3 (es) Un metodo de uso de un derivado quinolincarboxilico y su procedimiento de preparacion.
ES2053652T3 (es) N-(alquilideno sustituido)-1,2,3,4,-tetrahidro-9-acridinaminas, un procedimiento para su preparacion y su uso como medicamentos.
BR9813775A (pt) Uso de um composto, processo para o tratamento de uma condição de cefaléia vascular, e, composição farmacêutica adequada para uso no tratamento de uma condição de cefaléia vascular.

Legal Events

Date Code Title Description
TC Change of name
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A,8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1909 DE 07/08/2007.